Shares of Healthequity Inc (NASDAQ:HQY) rose sharply in today’s pre-market trading as the company reported better-than-expected first-quarter financial…
Microbot Medical Inc. (NASDAQ:MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company's common stock at a purchase price of $1.50 per share of
Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption (IDE) application for its LIBERTY Endovascular Robotic Surgical System.